CYP 0.00% 25.0¢ cynata therapeutics limited

Ann: Compelling Results from Pre-Clinical Stem Cell Study in GvHD-CYP.AX, page-50

  1. 715 Posts.
    lightbulb Created with Sketch. 19
    Moreforme i'm surprised by your resentment and negativity towards CYP, it's a BIG
    market out there, even MSB has its problems, all you're saying to me is that you're
    insecure about MSB.
    Anyway good luck with that.
    Don't bother to reply it won't do your image any good
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.